Back
Journey Medical 10K Form
Buy
66
DERM
Journey Medical
Last Price:
$6.57
Seasonality Move:
24.77%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-05-14 | 10Q | DERM/Journey Medical Quarterly |
2023-11-13 | 10Q | DERM/Journey Medical Quarterly |
2023-08-10 | 10Q | DERM/Journey Medical Quarterly |
2023-05-22 | 10Q | DERM/Journey Medical Quarterly |
2022-11-10 | 10Q | DERM/Journey Medical Quarterly |
2022-08-09 | 10Q | DERM/Journey Medical Quarterly |
Receive DERM News And Ratings
See the #1 stock for the next 7 days that we like better than DERM
DERM Financial Statistics
Sales & Book Value
Annual Sales: | $56.1M |
---|---|
Cash Flow: | $2.2M |
Price / Cash Flow: | 58.24 |
Annual Sales: | $0.96 |
Price / Book: | 7.18 |
Profitability
EPS (TTM): | -0.74000 |
---|---|
Net Income (TTM): | $-14.7M |
Gross Margin: | $35.3M |
Return on Equity: | -97.05% |
Return on Assets: | -20.79% |
Journey Medical Earnings Forecast
Key Journey Medical Financial Ratios
-
The Gross Profit Margin over the past 6 years for DERM is 62.81%.
-
The Selling, General & Administrative Expenses for DERM have been equal to 71.62% of Gross Profit Margin.
-
The Research & Development expenses have been 17.56% of Revenue.
-
The Net Earning history of DERM is -26.14% of Total Revenues.
-
Per Share Earnings over the last 6 years have been positive in 3 years.
Journey Medical Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Pharmaceuticals |
Sector: | Health Care |
Current Symbol: | DERM |
CUSIP: | 24983L |
Website: | journeymedicalcorp.com |
Debt
Debt-to-Equity Ratio: | 1.24 |
---|---|
Current Ratio: | 1.37 |
Quick Ratio: | 0.87 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 0 |
DERM Technical Analysis vs Fundamental Analysis
Buy
66
Journey Medical (DERM)
is a Buy
Is Journey Medical a Buy or a Sell?
-
Journey Medical stock is rated a BuyThe current Journey Medical [DERM] share price is $6.24. The Score for DERM is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.